Discover how the CMAR study revealed that eradicating HCV dramatically improves survival rates in hepatocellular carcinoma patients, transforming cancer treatment approaches.
Exploring how hepatitis C virus eradication transforms hepatocellular carcinoma risk through antiviral therapies and ongoing challenges in liver cancer prevention.